Gilead Sciences funds research and programs addressing social and economic barriers to health equity in cancer care for underserved communities in several countries.
Corporate Giving - Gilead Sciences supports community organizations with programs that expand disease awareness, prevention and early intervention to advance health equity in underserved communities.
The Gilead Australia Community Grants Program funds Australian non-profits for innovative projects advancing care, education, and support in HIV, liver disease, metastatic breast cancer, and blood cancer.
The Gilead Sciences Grants Program funds nonprofit-led research, education, and community initiatives in HIV, liver disease, oncology, and hematology to advance science and medical knowledge.
Gilead Sciences Corporate Grants support nonprofit-led research and scientific projects aligned with Gilead’s therapeutic focus areas and mission, emphasizing compliance, transparency, and ethical standards.
Gilead Sciences' Giving in North America grant funds projects in the US and Canada advancing research, education, and access in HIV, liver diseases, oncology, and inflammatory/respiratory diseases.